DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 159 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $7,866,000 | -36.7% | 515,816 | +0.2% | 0.30% | +9.4% |
Q4 2015 | $12,434,000 | -13.7% | 514,648 | -12.3% | 0.28% | -26.3% |
Q3 2015 | $14,401,000 | -31.7% | 586,841 | -34.8% | 0.38% | -17.7% |
Q2 2015 | $21,083,000 | +21.3% | 900,000 | +16.1% | 0.46% | +2.2% |
Q1 2015 | $17,383,000 | – | 775,000 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |